Oramed Pharmaceuticals (ORMP) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.48
-0.25
-0.01
0.22

Details

Expected EPS
0.005
Actual EPS
-0.48
Surprise EPS
-0.49
Surprise Percent
-9,700%

Description

⁨Oramed Pharmaceuticals⁩ (⁦ORMP⁩) has reported earnings of ⁦-0.48⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts